Physician profile
Ling P Chen
NPI 1649216888
$3,115.04
in general payments reported to CMS, 2019-2025
18 companies · $750 in 2025
The $750 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $163 · 2021: $252 · 2022: $122 · 2023: $815 · 2024: $622 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864 · Education: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,864.31 |
| Education | $323.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $716.40 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $692.29 | 2023-2025 | |
| Minerva Surgical, INC | $288.89 | 2023 | |
| Abbvie INC. | $250.14 | 2020-2022 | |
| Hologic Sales and Service, LLC | $139.73 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Millicent US INC | $135.00 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $124.60 | 2019 | |
| Pfizer INC. | $119.72 | 2025 | |
| Therapeuticsmd, INC. | $114.67 | 2021-2022 | |
| Sage Therapeutics, LLC | $111.11 | 2020 | |
| Terumo Medical Corporation | $104.08 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $67.31 | 2025 | Neffy |
| Sumitomo Pharma America, INC. | $52.97 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $24.73 | 2019-2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $22.79 | 2019 | |
| Myovant Sciences INC. | $13.61 | 2021 | |
| Avion Pharmaceuticals | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ling Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.